FEB 24, 2016 1:00 PM PST

Actionable Insights Delivered Through the Complete GeneReader NGS System

Speaker
  • Senior Director and Global Development Lead, NGS, QIAGEN
    Biography
      John obtained his Ph.D. in Physiology and Neurobiology from the University of Connecticut in 1999. His postdoctoral research was at Yale School of Medicine under Dr. Paul Lizardi. John has been active in the NGS field since its inception, directly involved in establishing both 454 and Ion Torrent sequencing systems, as well as supporting enrichment technologies such as RainDance and AmpliSeq.
      John is currently a Senior Director and Global Development Lead for NGS Technologies at Qiagen Corporation. He has published 25 papers, sits on several scientific advisory boards and is an inventor on numerous issued patents and patent applications

    Abstract

    While next-generation sequencing has proven to be a very useful tool in basic research, two major hurdles remain for its broad adoption in the clinical research setting: lack of seamless workflow for routine clinical research use and truly relevant content to guide clinical research activities.
    This webinar will discuss QIAGEN's approach to address these two issues. Our speaker, Dr. John Leamon, will share his experience developing and launching the industry’s first complete NGS workflow: The GeneReader System. The GeneReader offers a fully integrated solution, addressing all steps of the workflow from DNA extraction to bioinformatics analysis and interpretation. It is engineered specifically for any laboratory as a powerful tool for clinical cancer research, including those with limited resources or lacking highly specialized expertise. To this end, the QIAGEN proprietary Knowledge Base was used to design a tumor panel to identify aberrations of value for clinical research. The GeneReader NGS System was then used to deliver clinical research insights in a laboratory setting. Testing was conducted with a set of colorectal cancer samples, and results confirmed with alternative testing platforms.
    The QIAGEN GeneReader NGS System is a fully integrated sequencing workflow, engineered specifically for clinical research purposes. This turnkey solution is purpose-built, focusing on the assays that matter most. 
     


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    Loading Comments...
    Show Resources
    Attendees
    • See more